Perfil
Mr. Michal Fisher is an Independent Director at CNS Pharmaceuticals, Inc. and a Chief Business Officer at BioGenCell Ltd. He is on the Board of Directors at CNS Pharmaceuticals, Inc. Mr. Fisher was previously employed as a Head-Corporate Development by LifeSci Partners.
He received his undergraduate degree from Bar-Ilan University and a graduate degree from Bar-Ilan University.
Cargos activos de Michal Fisher
| Empresas | Cargo | Inicio |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 04/05/2026 |
BioGenCell Ltd.
BioGenCell Ltd. BiotechnologyHealth Technology Develops cellular therapies that treat blood flow problems | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Michal Fisher.
| Empresas | Cargo | Fin |
|---|---|---|
LifeSci Partners
LifeSci Partners Miscellaneous Commercial ServicesCommercial Services Operates as an integrated life sciences consulting platform that offers investor relations, investment banking, communications and strategy consulting | Corporate Officer/Principal | 02/01/2025 |
Formación de Michal Fisher.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Bar-Ilan University
Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioGenCell Ltd.
BioGenCell Ltd. BiotechnologyHealth Technology Develops cellular therapies that treat blood flow problems | Health Technology |
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
LifeSci Partners
LifeSci Partners Miscellaneous Commercial ServicesCommercial Services Operates as an integrated life sciences consulting platform that offers investor relations, investment banking, communications and strategy consulting | Commercial Services |
- Bolsa de valores
- Insiders
- Michal Fisher
















